Introduction {#s1}
============

Transporters -- also known as pumps -- and channels both mediate the transfer of ions and molecules across biological membranes. But the two are thermodynamically contrasting: transporters require the input of external energy while channels are passive, meaning the substrate simply diffuses down its electrochemical gradient. Except in rare cases, transporters and channels correspond to separate, unrelated structural families. CLC proteins are one of the exceptions. Channel-forming CLCs are passive Cl^−^ conductors ([@bib25]; [@bib38]), while transporter-forming CLCs exchange, with fixed stoichiometry, two Cl^−^ ions and one proton (H^+^) in opposite directions (i.e., they are Cl^−^/H^+^ antiporters) ([@bib2]; [@bib45]; [@bib52]). The external energy input in CLC transporters comes from the energetic coupling of the transported ions, Cl^−^ and H^+^, such that the electrochemical gradient of one ion drives movement of the other. The puzzling aspect of this dual functionality within the CLC protein family is that at the level of amino acid sequence, the distinction between the channels and transporters is not apparent.

Conceptually, the distinction between channels and transporters in general has been explained in terms of gating models that invoke one or two primary gates: channels are described as pores with one gate and transporters as pores with two gates that are never permitted to open simultaneously ([Figure 1](#fig1){ref-type="fig"}) (for review see \[[@bib17]\]). While it is true that channels and transporters are most often unrelated structurally, the gating model description implies that, in principle, similar structures could give rise to both, as one can imagine that a transporter could become a channel if one or both gates are compromised. CLC channels seem to fall under this category of channels that emerged from a family of transporters ([@bib4]; [@bib35]; [@bib39]).

![Passive and active transport explained by gating mechanisms.\
One-gate (**A**) and two-gate (**B**) models explaining passive transport by a channel and active transport by a transporter (shown is an antiporter). Direction of the solute electrochemical gradient is indicated by a wedge (the thicker end means more positive).](elife-36629-fig1){#fig1}

Structural and functional studies support a plausible mechanistic model for the operation of CLC transporters. CLC transporter structures show a narrow Cl^−^ transport pathway with three consecutive Cl^−^-binding sites, referred to as S~ext~, S~cen~ and S~int~, for external (nearest the extracellular solution), central and internal (nearest the intracellular solution), respectively. Chloride is observed at these sites in various structures ([@bib9]; [@bib10]; [@bib15]; [@bib24]). In addition, the transporters all contain a glutamate residue positioned such that its side chain carboxylate group can bind either at S~ext~ or S~cen~ -- in competition with a Cl^−^ ion -- or reside in the extracellular solution. Thus, CLC transporters are like Cl^−^ channels with a weird feature -- a glutamate side chain that clogs its own pore. This led to the idea that glutamate might not only be a competitor for the Cl^−^ binding sites as the structures suggest, but it might also transfer a proton from inside to out (or the reverse) when it moves between its S~cen~ position to its extracellular position ([@bib15]; [@bib16]). The transfer would naturally give rise to the 2:1 Cl^−^:H^+^ exchange stoichiometry characteristic of CLC transporters because 2 Cl^−^ ions must be displaced when the glutamate gate moves between the extracellular solution and S~cen~. This mechanism is consistent with the demonstrated conversion of a CLC transporter into a passive (but slow) Cl^−^ channel upon mutation of the glutamate, as well as the demonstrated ability of small carboxylate-containing organic acids to compete with Cl^−^ inside the pore ([@bib1]; [@bib2]; [@bib16]). But there was one important caveat to make this transporter mechanism work: there must exist a relatively high kinetic barrier to Cl^−^ flow near the intracellular side of the pore ([@bib15]). This barrier would serve as the 'second gate' in the gating model conceptualization of transporters. So far, data for CLC transporters seem consistent with this mechanism: they have a channel-like pore, an external 'glutamate gate' that competes with Cl^−^ binding and (presumably) transfers H^+^ across the membrane, and structurally what appears to be a relatively high resistance (i.e., a large kinetic barrier) to Cl^−^ flow near the intracellular aspect of the pore (i.e., the pore there is very narrow.)

Less is known about the chemistry and structure of CLC channels. Only one CLC channel structure has been determined, CLC-K from *Bos taurus* (referred to as bCLC-K or shortly CLC-K) ([@bib42]). This is a special case, a rare type of CLC channel that can be distinguished from CLC transporters based on its amino acid sequence because it does not have a 'glutamate gate'. That difference alone renders CLC-K inert to H^+^ transfer. The structure of CLC-K also revealed a wider pore diameter on the intracellular side, consistent with a lowered kinetic barrier to Cl^−^ flow. CLC-0/1/2 channels, by contrast, contain a 'glutamate gate' and are not distinguishable from CLC transporters by sequence. Thus, there must be an even more subtle distinction between these CLC channels and the transporters. Why does the glutamate gate in these channel CLCs not give rise to H^+^ transfer coupled to Cl^−^ transfer? Is a reduced kinetic barrier to Cl^−^ flow near the intracellular side, suggested by the CLC-K structure, a common feature in CLC channels? To address these questions, we have determined the structure of CLC-1 from *Homo sapiens* (referred to as hCLC-1 or CLC-1).

We are also interested in the CLC-1 channel because it plays an important role in membrane repolarization of skeletal muscle cells following muscular contraction, and its mutation in humans causes hereditary muscle disorders known as *myotonia congenita* ([@bib18]; [@bib28]; [@bib33]; [@bib55]).

Results {#s2}
=======

Determination of a human CLC-1 channel structure by cryo-EM {#s2-1}
-----------------------------------------------------------

We purified the CLC-1 protein in mild detergent from cultured human cells and examined them by cryo-EM single particle analysis ([Figure 2](#fig2){ref-type="fig"} and [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}). Despite its small molecular size (200 kDa), particles showed good contrast on micrographs under the optimized freezing and data acquisition conditions ([Figure 2A](#fig2){ref-type="fig"}). Two-dimensional (2D) class averages of selected particles displayed 2-fold rotational symmetry around an axis normal to the membrane (detergent micelle) ([Figure 2B](#fig2){ref-type="fig"}), as expected from the homodimeric architecture of CLC proteins ([@bib9]; [@bib34]; [@bib38]). After removing artifacts and damaged particles by 2D classification, a density map was reconstructed at 3.9 Å resolution with C2 symmetry imposed ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). This map showed a well-resolved transmembrane domain (TMD) with clearly visible α-helical features. By contrast, density for the carboxy-terminal cytosolic domain (CTD) was lower quality, suggesting conformational flexibility in this region.

![Cryo-EM structure of the human CLC-1 channel.\
(**A**) Representative micrograph of the purified CLC-1 channel (scale bar, 50 nm) on a cryo-EM grid. Representative particles (white squares) are magnified and shown in the right panels. (**B**) Images of selected 2D classes from reference-free 2D classification by RELION. Scale bar, 10 nm. (**C** and **D**) Cryo-EM density map (**C**) and atomic model (**D**) of the hCLC-1 channel. The transmembrane domain (TMD; blue and salmon) and the cytosolic domain (CTD; light blue and tan) were separately refined and combined for visualization. Ext, extracellular side. Int, intracellular side. The approximate lipid bilayer region is shown by arrows.](elife-36629-fig2){#fig2}

To improve the map quality, we subjected particles to a round of 3D classification ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). The results demonstrated that while the TMD is largely indistinguishable between classes, the CTDs deviate from each other by pivotal movements of varying degrees ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Based on this, we pooled \~170,000 particles from the two most populated and structurally similar classes, which correspond to 50% of particles. This particle set led to an improved density map at an overall resolution of 3.6 Å (data not shown). Using masking techniques to isolate individual regions, the resolution of the TMD was further improved to 3.4 Å ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}, [Video 1](#video1){ref-type="video"}). The CTD remained poorly defined, likely due to continuous pivotal movements of its two wing-like structures ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}, [Video 1](#video1){ref-type="video"}).

###### Cryo-EM structure of the human CLC-1 channel.

The cryo-EM map and atomic model of human CLC-1 are illustrated. Also see [Figure 2C and D](#fig2){ref-type="fig"}.

10.7554/eLife.36629.007

The good quality TMD density map enabled building a molecular model that included nearly all side chains ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, and [Video 1](#video1){ref-type="video"}). The model was refined using Rosetta ([@bib57]). The CTD map did not show side chain density but we could dock with confidence the crystal structure of the CLC-0 CTD ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}) ([@bib37]). Both CLC-1 and CLC-0 channels contain a large loop extending from the CTD's cystathionin-β-synthase (CBS) domains, which was not visible in either the EM density map or the crystal structure. The function of the CTD is poorly understood; it may even be dispensable for ion transport given its high tolerance to mutation ([@bib12]) and absence in most bacterial CLC transporters.

Bifurcated pore structure of CLC-1 {#s2-2}
----------------------------------

The TMD of CLC-1 exhibits the canonical dimeric architecture of a CLC protein ([Figure 2C,D](#fig2){ref-type="fig"}). Each monomer is roughly a triangular prism shape and contains a complete ion transport pathway that appears structurally independent from that of the neighboring monomer. As in other CLC structures ([@bib9]; [@bib10]; [@bib15]; [@bib42]), the Cl^−^ transport pore in CLC-1 is most narrowly constricted halfway across the membrane, within the region referred to as the selectivity filter ([Figure 3A](#fig3){ref-type="fig"}). Overall, the pore lining is charged positive to attract Cl^−^ ([Figure 3B](#fig3){ref-type="fig"}).

![Bifurcated pore structure of the CLC-1 channel.\
(**A**) The canonical Cl^−^ transport pathway (green) and the second intracellular pore (yellow) are depicted in a side view of CLC-1. The pores of only one monomer are shown for simplicity. (**B**) Surface electrostatistics of CLC-1's pore lining. The protein surface was clipped to show optimally the pore lining of the CLC-1 monomer on the left. The yellow arrowhead indicates the position of the selectivity filter. The insets show views into the pore entrances, which are marked with asterisks. (**C**) A view into the second intracellular pore entrance from the cytosolic surface was compared to equivalent views with other CLC proteins. In the CLC-1 panel, the pore is indicated by a dashed gray circle. Amino acids lining the pore were indicated with their side chain atoms shown in ball-and-stick representation.](elife-36629-fig3){#fig3}

In contrast to other CLC proteins the potential route for ion diffusion in CLC-1 is bifurcated on the intracellular side of the selectivity filter-- one following the canonical Cl^−^ transport pathway found in all CLC proteins and the 'second' pore directed toward the protomer-protomer boundary on the cytosolic surface, which is distinctive in CLC-1 ([Figure 3A,B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Both branches of the bifurcation are potentially hydrated because the radius is greater than that of water (1.4 Å) and the linings contain chemical groups with hydrogen bonding potential. A branch equivalent to CLC-1's secondary pore in the CLC-K channel is sealed off by F222 and V226 (corresponding to F288 and V292 of CLC-1) due to a different αH helix position ([Figure 3C](#fig3){ref-type="fig"}). In transporters, only a much narrower (\~0.9--1.0 Å radius) pore could be detected, where stable dwelling of water molecules seems unlikely ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In the *E. coli* transporter (EcCLC), the pore is further capped near the cytosolic surface by E203 (corresponding to V292 of CLC-1). We note that E203 of EcCLC and the equivalent Glu of mammalian CLC-4 and CLC-5 transporters have been implicated in shuttling H^+^ between the intracellular solvent and the protein interior ([@bib30]; [@bib31]; [@bib60]) by side-chain protonation and deprotonation, although this feature does not seem to be essential for H^+^ transport in other cases, including the *C. merolae* transporter (CmCLC) ([@bib15]; [@bib16]; [@bib44]). It is possible that during Cl^−^/H^+^ exchange cycles, the αH helix of transporters transiently undergoes a conformational change such that a water-accessible pore is formed similarly to the CLC-1 case, which might facilitate H^+^ transfer. Unlike transporter-type CLCs, the CLC-1 channel does not transport H^+^ in a manner tightly coupled to Cl^−^ and thus it is unclear whether CLC-1's second intracellular pore is utilized for ion transport. Cl^−^ ions may move through this pore in addition to the primary Cl^−^ pathway.

Chloride-selectivity filter and bound Cl^−^ ions {#s2-3}
------------------------------------------------

The CLC-1 structure shows an anion selectivity filter largely similar to other CLC proteins but with some distinctive features ([Figure 4A](#fig4){ref-type="fig"} and [Video 2](#video2){ref-type="video"}). The filter is formed at the central constriction of the Cl^−^ pathway by αN, αF, and αD helices, all of which point their N-terminal ends towards the center where Cl^−^-binding sites are formed. This arrangement contributes to an electrostatically positive environment at the Cl^−^-binding sites through α-helix end charges. Backbone nitrogen atoms from αN and αF segments are arranged to coordinate a partially dehydrated Cl^−^ ion near the extracellular end of the constriction (external site or S~ext~). In the CLC-1 density map we observe a clear density feature at S~ext~, which likely corresponds to a bound Cl^−^ ion ([Figure 4A](#fig4){ref-type="fig"} and [Video 2](#video2){ref-type="video"}). Typically, CLC proteins have two additional Cl^−^-binding sites, namely, central (S~cen~) and internal (S~int~) sites ([@bib10]). S~cen~ has been observed to bind a Cl^−^ ion through polar interactions with one or two backbone nitrogen atoms and the side chains of the conserved tyrosine (denoted Tyr~C~; Y578 of CLC-1 or Y445 of EcCLC) and serine residues (denoted Ser~C~; S189 of CLC-1 or S107 of EcCLC) ([@bib9]; [@bib10]). In the EcCLC transporter, S~cen~ has been shown to bind Cl^−^ relatively strongly (Kd \~1 mM) ([@bib32]; [@bib46]). S~int~ is largely exposed to the intracellular solvent and binds Cl^−^ with lower affinity (K~d~ \>20 mM) ([@bib32]; [@bib46]). In the CLC-1 map (determined in the presence of 116 mM Cl^−^), S~int~ shows a density peak whose intensity is comparable to that of the S~ext~ density ([Figure 4A](#fig4){ref-type="fig"} and [Video 2](#video2){ref-type="video"}). By contrast, we do not observe density for an ion at S~cen~ above the noise level, suggesting that S~cen~ of CLC-1 may have a lower Cl^−^ occupancy than S~ext~ and S~int~. This is somewhat surprising given the conservation of structural elements for S~cen~, including Tyr~C~ and Ser~C~. Perhaps subtle structural differences account for the absence of an ion at this site compared to other CLC proteins. For example, we note that the position of Tyr~C~ is shifted away from S~cen~ by \~1.5 Å (see [Figure 5B](#fig5){ref-type="fig"}).

![Glutamate gate (Glu~gate~) and Cl^−^-binding sites of CLC-1.\
(**A**) View (stereo) into the selectivity filter of CLC-1. αN, αF, αR, and αC-D segments (Cα trace and side chains) are shown in cyan, salmon, yellow, and olive, respectively. The side chains of Glu~gate~, Tyr~C~, and Ser~C~ are represented with balls and sticks. Cl^−^-binding sites are indicated by green (S~ext~ and S~int~) and gray (S~cen~) spheres. The cryo-EM density map is shown in mesh (S~ext~ and S~int~ in magenta and the rest in gray). (**B**) Water-accessible regions in the filter region, probed by Hollow ([@bib21]), are shown with purple (extracellular vestibule) and blue (intracellular vestibule) dots. Glu~gate~ is represented in ball-and-stick. (**C**) Comparison of Glu~gate~ positions between the CLC-1 channel and CLC transporters. The amino acid segments 146--149 and 355--358 forming the anion selectivity filter were aligned between structures. Cα-traces of the segments are shown with the Glu~gate~ side chains in ball-and-stick representation. Blue, CLC-1. Light orange, WT EcCLC (PDB ID: 1OTS). Yellow, EcCLC E148Q mutant (PDB ID: 1OTU). Magenta, CmCLC (PDB ID: 3ORG). Gray spheres represent the positions of Cl^−^ ions seen in EcCLC E148Q mutant (S~ext~ and S~cen~). Note that the Cl^−^ ion at CLC-1's S~ext~ (not shown) essentially coincides with S~ext~ of EcCLC.](elife-36629-fig4){#fig4}

![Structure of the αC-D loop and Ser~C~.\
(**A**) Atomic model and cryo-EM density of the CLC-1 αC-D. (**B**) Comparison of the αC-D and αR segments (shown in Cα-only trace) among CLC channels and transporters. The side chains of Ser~C~ and Tyr~C~ are shown in sticks.](elife-36629-fig5){#fig5}

###### Glutamate gate (Glu~gate~) and Cl^−^-binding sites of CLC-1.

The selectivity filter region of human CLC-1 is shown. The same color scheme and representation are used in [Figure 4A](#fig4){ref-type="fig"}.

10.7554/eLife.36629.013

New conformation of the gating glutamate {#s2-4}
----------------------------------------

Like transporter-type CLC proteins and in contrast to CLC-K, the CLC-1 channel has a Glu~gate~, but in CLC-1 it adopts a notably different conformation than previously observed in CLC transporters ([Figure 4](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Based on previous studies on transporters ([@bib9]; [@bib10]; [@bib15]), Glu~gate~, located in the immediate vicinity of S~ext~ and S~cen~, plays a key role in ion transport: when deprotonated its side-chain carboxylic moiety resides in either the S~ext~ or S~cen~ Cl^−^ binding sites, preventing the binding of a Cl^−^ ion therein. In the CLC-1 structure, the Glu~gate~ side chain occupies neither S~ext~ nor S~cen~, but instead it is oriented in a different direction. The difference in Glu~gate~'s conformation is mainly due to changes in its side-chain rotamer, whereas the polypeptide backbone arrangement in this region is similar among the structures ([Figure 4C](#fig4){ref-type="fig"}). The observed Glu~gate~ conformation is also different than the outwardly-oriented (side chain projecting into the extracellular funnel) conformation that has been seen in the structure of an EcCLC Glu-to-Gln (E148Q) mutant ([Figure 4C](#fig4){ref-type="fig"}), which is hypothesized to mimic the protonated state of Glu~gate~ ([@bib10]).

It is unclear whether the Glu~gate~ in the CLC-1 structure (determined at pH 7.4) is protonated. The pKa of the Glu~gate~ side chain might be shifted towards a more neutral pH as it is neighbored by multiple hydrophobic amino acids ([@bib22]). Yet, Glu~gate~ at this position is more likely deprotonated because its side chain seems exposed to water molecules due to the presence of the second intracellular pore ([Figure 4B](#fig4){ref-type="fig"}). In CLC transporters, this conformation would be highly unfavorable because it would produce steric clashes with neighboring side chains (equivalent to V236, V265, and F279 of CLC-1; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), which are moved away in CLC-1 by a shift of the αG and αH helices. In other words, this conformation of Glu~gate~ does not seem possible in CLC transporters studied so far.

The observed Glu~gate~ conformation of CLC-1 was unexpected because it was never observed in other CLC protein structures, and yet it is consistent with an open CLC-1 channel, which is expected in the absence of an applied membrane potential. CLC-1 is a voltage-gated channel, which closes when the membrane potential is negative (i.e., at its 'resting' value) ([@bib13]; [@bib47]). Perhaps in the presence of an applied negative membrane potential the Glu~gate~ side chain moves into either the S~ext~ or S~cen~ position, as seen in CLC transporters, and prevents Cl^−^ conduction. This possibility would account for the observation that CLC-1 and related CLC-0 conduct Cl^−^ ions at all membrane voltages when the Glu~gate~ residue is mutated to Gln ([@bib10]; [@bib14]).

'Transporter-like' αC-D loop {#s2-5}
----------------------------

The previous CLC-K channel structure has suggested that a wider pore diameter between S~cen~ and S~int~ is crucial for its channel function ([@bib42]). In CLC transporters, a kinetic barrier for Cl^−^ passage (i.e., a narrowing of the pore) exists on the intracellular side of the vestibule to preclude slippage of Cl^−^ ions during the Cl^−^/H^+^ exchange cycle ([@bib15]). This barrier is due to a narrow pore width between S~cen~ and S~int~, which is created in part by Ser~C~ of the αC-D loop interposed between the two Cl^−^ binding sites. In the CLC-K structure, the αC-D loop has a distinctly different conformation, where Ser~C~ is flipped down and thus no longer interposed between the two Cl^−^ binding sites. Consequently, the pore diameter is wider such that Cl^−^ ions will more readily permeate. Given that CLC-1 is also a channel, we wondered whether the αC-D loop in CLC-1 would adopt a similar 'flipped-down' conformation.

While a different conformation of the αC-D loop is a key feature distinguishing CLC-K from transporters, a structural comparison shows that this is not the case for the CLC-1 channel ([Figure 5](#fig5){ref-type="fig"}). In contrast to CLC-K, the αC-D loop in CLC-1 adopts the loop conformation seen in CLC transporters, especially CmCLC ([@bib15]). Consequently, the Ser~C~ side chain is positioned between S~int~ and S~cen~ ([Figure 5B](#fig5){ref-type="fig"}). Therefore, in the case of CLC-1 the αC-D loop itself does not provide an explanation for why CLC-1 functions as a Cl^−^ channel (see below). This also suggests that the 'flipped-down' conformation of Ser~C~ may be unique to the CLC-K channel.

Comparison of Cl^−^ pore structures of CLC proteins {#s2-6}
---------------------------------------------------

To understand why CLC-1 functions as a channel we compared its Cl^−^ pore structure to that of other CLC proteins. In both CLC-1 and CLC-K channels, a continuous Cl^−^ pathway was evident in between the extracellular and intracellular funnels, through the selectivity filter ([Figure 6A,B](#fig6){ref-type="fig"}). In the EcCLC and CmCLC transporters, a continuous pore could be detected only when the Glu~gate~ side-chain atoms (from Cβ) were excluded from the pore radius calculation as Glu~gate~ sits at S~ext~ or S~cen~ ([Figure 6C,D](#fig6){ref-type="fig"}). These results would therefore reflect the pore structure when the transporter's Glu~gate~ transiently moves away from the Cl^−^ pathway upon protonation (hypothetically, akin to the crystal structure of the EcCLC E148Q mutant). However, we note that calculated pore radii around S~ext~ may be somewhat overestimated due to the actual presence of the Glu~gate~ side-chain atoms.

![Profile of the Cl^−^ transport pore and the kinetic barrier between S~cen~ and S~int~.\
Pore structures along the Cl^−^ pathway are shown in dot representation together with amino acids around it. Glu~gate~, Tyr~C~, and Ser~C~ side chains are shown in ball-and-stick representation. The color scheme is the same as in [Figure 4](#fig4){ref-type="fig"}. Pore-lining amino acids that are distinctive between CLC channels and transporters are shown in gray.](elife-36629-fig6){#fig6}

The CLC-1 channel has the narrowest (1.0 Å in radius) constriction above S~ext~ toward the extracellular side due to the placement of the M485 side chain near the external end of the Cl^−^ pathway ([Figure 6A](#fig6){ref-type="fig"}). While the radius is significantly smaller than the Cl^−^ radius (\~1.7 Å), the flexibility of the M485 side chain must allow Cl^−^ ions to pass through this region. Given the narrowness of this constriction, it is likely that M485 affects the Cl^−^ throughput of the channel. In fact, its mutation to less flexible valine (M485V) causes recessive myotonia congenita and has been shown to reduce the single channel conductance of CLC-1 to about 20% of the wild type channel conductance ([@bib59]).

From S~ext~ to the intracellular opening the CLC-1 channel structure shows a relatively wide pore opening despite its 'transporter-like' αC-D loop. This suggests the absence of a large kinetic barrier in CLC-1, but for reasons other than the αC-D loop conformation. Compared to the CLC-K channel, CLC-1 has a slightly narrower (1.5 Å vs 1.7 Å in radius) opening between S~cen~ and S~int~ because of Ser~C~. This might create a kinetic barrier to some degree, but the pore is still significantly wider and more hydrophilic than the equivalent region in the EcCLC transporter ([Figure 6C](#fig6){ref-type="fig"}). The difference originates mainly from two amino acids (T475 and G483) lining the constriction. In EcCLC, the equivalent positions are F348 and I356, which project their bulky, hydrophobic side chains towards the Cl^−^ pathway between S~cen~ and S~int~. Together with proximal placement of Ser~C~ and Tyr~C~, this narrows the opening (1.0 Å in radius) in EcCLC. In the CmCLC transporter, the constriction at the kinetic barrier region is wider (1.6 Å in radius) than EcCLC because of smaller side chains at the equivalent positions (I421 and V429; [Figure 6D](#fig6){ref-type="fig"}) and a slight downward shift (1.5 Å) of Ser~C~ with respect to the positions in EcCLC ([Figure 5B](#fig5){ref-type="fig"}). Yet, hydrophobicity provided by the I421 and V429 side chains might result in a significantly higher kinetic barrier than in CLC-1.

It is noteworthy that the CLC-1 channel shows a 1.5 Å outward shift of the Tyr~C~ side chain with respect to the position that is almost invariant in the other CLC structures ([Figure 5B](#fig5){ref-type="fig"}). In CLC-1, this shift contributes to pore widening in the cytosolic vestibule. At present it is unclear if this shift of Tyr~C~ is static or part of dynamic movements in CLC-1 and if it is unique in CLC-1 or a similar movement exists in other CLC proteins. Previous biophysical studies have proposed a movement of Tyr~C~ to explain alternating gate opening of the EcCLC Cl^−^/H^+^ transporter ([@bib6]; [@bib23]; [@bib26]). On the other hand, EcCLC crystal structures obtained with a number of different variants and crystallization conditions have not yet revealed any movement of Tyr~C~.

Distinctive amino acid pattern between CLC channels and transporters around the kinetic barrier region {#s2-7}
------------------------------------------------------------------------------------------------------

Because the CLC-1 structure suggests that T475 and G483 (equivalent to F348 and I356 in EcCLC, respectively) likely contribute to lowering of the kinetic barrier, we compared amino acids lining this region among both CLC channels and transporters ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Indeed, these two positions showed a distinctive differential pattern when comparing CLC channels and transporters, whereas other positions (i.e., H369, C481, L577, and I581 in CLC-1) did not. Generally, these two positions are filled with large, hydrophobic amino acids in transporters but are replaced by a small, polar amino acid in CLC channels. One notable outlier is position 417 of the CLC-K channels (Y425). However, the CLC-K channel structure shows that its phenyl side chain is skewed off the Cl^−^ pathway, and thus does not seem to create a kinetic barrier in CLC-K ([Figure 6B](#fig6){ref-type="fig"}). In fact, it forms the S~cen~ Cl^−^ binding site together with Tyr~C~ and F519 through anion-quadrupole interactions ([@bib42]) ([Figure 6B](#fig6){ref-type="fig"}). In summary, the observed amino acid pattern and structural information suggest that a lowered barrier in the S~cen~--S~int~ region of the pore is a common feature of CLC channels, but CLC-1 and CLC-K channels achieve this somewhat differently. In the CLC-1 channel, small side chains in pore-lining residues lower the kinetic barrier, whereas in CLC-K mainly the reorientation of Ser~C~ lowers it. The extent of the kinetic barrier should also be affected by the hydrophobic and electrostatic nature of the lining residues, not only the physical dimensions of the pore.

Working model and experimental validation {#s2-8}
-----------------------------------------

Combining the new structural information and previous data, we propose a working model that channel behavior in CLC proteins arises out of the following physical conditions ([Figure 7](#fig7){ref-type="fig"}): (1) Glu~gate~ is either absent (i.e., in CLC-K) or allowed to reside in an 'open' configuration (i.e., CLC-1) for a sufficiently extended period of time (rather than occupying S~ext~ or S~cen~); (2) a lowered kinetic barrier between S~cen~ and S~int~; (3) reduced Cl^−^-binding affinity at S~cen~ (or S~ext~, as suggested by apparent low occupancy in the CLC-K structure). A reduced kinetic barrier would be an important feature to achieve fast Cl^−^ throughput. On the other hand, a sufficient kinetic barrier would be crucial in transporters to preclude undesired slippage of Cl^−^ ions through the transiently open pore ([@bib15]). In addition, reduction of Cl^−^-binding affinity at S~cen~ and/or S~ext~, which is energetically related to the kinetic barrier, might also contribute to high Cl^−^ throughput in channels. For example, relatively deep energy wells at S~cen~ and S~ext~, as implied by the high occupancy of sites in the EcCLC transporter, would create a larger energy difference between the binding sites and the 'transition states', which effectively raises the energy barrier. In CLC-1 the relatively low binding site occupancy implies not very deep energy wells and thus a smaller energy difference between the binding sites and 'transition states'.

![Models for ion transport mechanisms of CLC transporters and channels.\
(**A**) General architecture of CLC proteins. F348 and I356 are labelled according to *E. coli* transporter (EcCLC) numbering. (**B**) Model for 2:1 Cl**^−^**/H^+^ exchange by CLC transporters. The negatively-charged carboxylic group of the Glu~gate~ side chain can occupy S~ext~ (state 2) or S~cen~ (state 3) by a swinging motion, competing with a Cl**^−^** ion for binding therein. When protonated at S~cen~ by a proton transferred from the cytosol (state 4), the Glu~gate~ side chain flips out to the extracellular side (state5). The kinetic barrier between S~cen~ and S~int~ would prevent leakage of Cl**^−^** ions through the open pore during this transient step. Also, as seen previously with EcCLC ([@bib46]), synergistic binding of two Cl**^−^** ions at S~ext~ and S~cen~ (depicted by solid gray curves around S~ext~ and S~cen~) might further deter slippage of Cl**^−^** ions. Deprotonation resets the cycle (state1). The cycle is reversible, and for simplicity the intermediate steps were omitted. Cl**^−^** ions and H^+^ are depicted as green and blue spheres, respectively. (**C**) Model for the CLC-1 channel. The cryo-EM structure of CLC-1 presented in this study represents the depolarized state. Although the conformation of the αC-D loop remains similar to that of transporters, CLC-1's kinetic barrier is lower than transporters due to the lack of additional kinetic barrier elements. In addition, weak Cl**^−^**-binding affinity at S~cen~ might facilitate rapid permeation of Cl**^−^** ions along the pore. When the membrane potential is negative (resting), the Glu~gate~ side chain may occupy S~ext~ or S~cen~ as in transporters, blocking the pore. (**D**) Model for CLC-K channels. The outer gate is removed by a natural mutation of Glu~gate~ to valine (V166). The kinetic barrier is largely reduced due to a flip-down of Ser~C~, as well as lack of other kinetic barrier elements. The cryo-EM structure suggested that S~ext~ and S~cen~ have weaker Cl**^−^**-binding affinity than transporters (empty and with a semi-transparent Cl**^−^** sphere).](elife-36629-fig7){#fig7}

We carried out biophysical experiments to test some of these ideas using the EcCLC transporter ([Figure 8A,D](#fig8){ref-type="fig"}). EcCLC mutants were produced, purified and reconstituted into lipid vesicles for assessment of Cl^−^ and H^+^ transport activity ([Figure 8](#fig8){ref-type="fig"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}) ([@bib16]; [@bib23]; [@bib56]). The ideas outlined above predict that if the kinetic barrier in EcCLC is lowered it should behave more like a CLC channel (i.e., rapid Cl^−^ permeation with decreased H^+^ transport activity). Cl^−^ permeation is expected to be further increased if the Glu~gate~ is rendered persistently opened. As reported previously ([@bib23]), opening of Glu~gate~ alone by the Glu-to-Ala mutation (E148A) abolishes the H^+^ transport activity, but it also reduced Cl^−^ throughput by a factor of approximately 0.25. We reason that this is likely because the mutant still retains the kinetic barrier deterring Cl^−^ ions from moving between S~cen~ and S~int~. Thus, while removal of the Glu~gate~ is sufficient to convert the transporter into a Cl^−^ channel, a reduced kinetic barrier would be key to an increased Cl^−^ throughput, an important feature of the native CLC channels.

![Effects of Glu~gate~ and kinetic barrier mutations on Cl^−^ and H^+^ transport activities of EcCLC.\
(**A**) Schematics of the Cl^−^ dump assay to measure the Cl**^−^** transport rate of EcCLC. Purified EcCLC protein is reconstituted into proteoliposomes containing 300 mM KCl inside. Buffer outside the liposomes was reduced to 150 mM K~2~SO~4~, lowering the Cl^−^ concentration outside to \~1 mM. Transmembrane ion flux was initiated by addition of the K^+^-ionophore valinomycin (Vln) and the protonophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP). Increase of the Cl^−^ concentration outside the liposomes was monitored using a Cl^−^-selective electrode. (**B**) and (**C**) Examples of raw traces of Cl^−^ dump assays. Vln/FCCP was added at t = 0. the gray arrowheads indicate addition of the β-octyl glucoside detergent to the reaction to release all Cl^−^ from liposomes. (**D**) Schematics of the fluorescence-based H^+^ influx assay to measure the H^+^ transport activity of EcCLC. EcCLC proteoliposomes containing 450 mM KCl inside were diluted to buffer containing 450 mM potassium gluconate, lowering Cl^−^ concentration outside to \~30 mM. The flux was initiated by addition of valinomycin at t = 100 *s*. As H^+^ are transported into the vesicles by EcCLC, intravesicular pH drops, which can be monitored by the quenching of 9-amino-6-chloro-2-methoxyacridine (ACMA) fluorescence. At the end of experiments (t = 1200 *s*), the protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) was added to release all H^+^ from the vesicles. (**E**) and (**F**) Examples of normalized fluorescence traces of ACMA-based H^+^ influx assay. Shown are means (line and symbols) and s.e.m. (band) of 4 experiments.](elife-36629-fig8){#fig8}

Previous studies have shown that when the E148A mutation is combined with a Tyr~C~ mutation (e.g., Y445S), the Cl^−^ transport rate dramatically increases ([@bib23]), demonstrating that efficient Cl^−^ channel activity can be produced from EcCLC by altering its gates. However, we note that Y445S is rather unphysiological as Tyr~C~ is invariant among all CLC channels and transporters. Therefore, here we examined the effects of lowering the kinetic barrier in wild type EcCLC by mutating Ser~C~ or neighboring pore-lining amino acids, guided by the CLC-1 and CLC-K structures ([Figure 8B,E](#fig8){ref-type="fig"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Trimming the side chain of Ser~C~ (S107G), with the intention of mimicking the flipped Ser~C~ in the CLC-K channel, increased the Cl^−^ transport rate by a factor of 2, as previously reported ([@bib23]). At the same time, this mutation lowered H^+^ coupling 3-fold, as one would expect due to the slippage of uncoupled Cl^−^ ions. Next, since CLC-K has a polar amino acid (Thr) at one of its pore-lining residues (F348 of EcCLC), we further introduced a similar (F348A) mutation. This increased the Cl^−^ throughput and almost abolished coupled H^+^ transport. Finally, by adding a Glu~gate~ mutation (E148A) to this double mutant the Cl^−^ throughput was further increased. Compared to the E148A single mutant, the triple mutant (S107G/F348A/E148A) has a Cl^−^ transport rate increased about 25-fold ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}).

Similar results were obtained when mutations mimicking the CLC-1 channel were introduced to EcCLC ([Figure 8C,F](#fig8){ref-type="fig"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). While single mutations at the pore-lining amino acids (F348T or I356G) did not increase the Cl^−^ transport rate, the double mutation (F348T/I356G) moderately increased the Cl^−^ throughput (1.5-fold with respect to the wildtype). We note that this mutant displayed no measurable H^+^ transport activity. When the double mutant was combined with the Glu~gate~ mutation (E148A), which was used as a surrogate of the Glu~gate~ conformation observed in the CLC-1 structure, the Cl^−^ throughput dramatically increased (22-fold with respect to the single E148A mutant; [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Single mutations (F348T or I356G) in the E148A background showed intermediate increases in Cl^−^ throughput, suggesting that the effects of these mutations are somewhat additive.

Discussion {#s3}
==========

The human CLC-1 channel exhibits interesting structural differences in the Cl^−^ transport pathway and the gates, which can explain why this protein functions as a Cl^−^ channel instead of a Cl^−^/H^+^ antiporter. The outer gate of the channel remains open because the carboxylic side-chain Glu~gate~ is located off to the side, away from the Cl^−^ transport pathway ([Figure 4](#fig4){ref-type="fig"}). The inner kinetic barrier seems to be substantially lowered compared to transporters owing to a wider pore diameter near the cytosolic side ([Figure 6](#fig6){ref-type="fig"}). The pore widening is subtle, but distinctive enough to reveal a pattern separating channels and transporters at the protein sequence level (independent of the presence or absence of a Glu~gate~) ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

The position of the Glu~gate~ residue in CLC-1 is unique among CLC structures so far observed. The new Glu~gate~ position, where its carboxylic side chain is directed off to the side of the Cl^−^ pathway, is enabled by a pocket that is large and hydrophilic (owing to its bifurcated pore structure) enough to accommodate Glu~gate~'s side chain. This pocket may also exist in other Glu~gate~-containing CLC channels (i.e., CLC-0 and CLC-2) but does not seem to exist in transporters because of a different arrangement of neighboring amino acids. It seems likely that this Glu~gate~ position is key to understanding why CLC-1 exhibits a stable open (i.e., conducting) state. On the basis of mutagenesis studies ([@bib10]; [@bib14]), the Glu~gate~ in CLC-0 and CLC-1 has been identified as a 'voltage sensor' because its removal abolishes voltage-dependent gating. From this observation, we would suggest that the position of Glu~gate~ (i.e., whether it resides off to the side, not occluding the pore, or within the pore) depends on the transmembrane voltage and generally dictates gating each CLC-1 monomer's pore (also referred to as a 'protopore').

An unresolved issue raised by the new Glu~gate~ side chain conformation is this: if this conformation corresponds to the conducting state, how is it favored by low pH outside ([@bib50])? One possibility is the Glu~gate~ might be protonated in this conformation. Alternatively, low pH might stabilize a conformation of Glu~gate~ outside the pore, as in the EcCLC E148Q mutant. This conformation would also remove Glu~gate~ from the pore and permit conduction. Finally, the pH effect might be produced allosterically by protonation of an unidentified amino acid on the extracellular side. For example, both CLC-2 and CLC-K channels are inhibited by external pH \<6.5, but it has been shown that a His residue (H532 of CLC-2 and H497 of CLC-K), which is located \~20 Å away from the pore, is responsible for this effect ([@bib20]; [@bib41]). This issue remains unresolved for now.

Functional experiments using EcCLC provide support for our model that a low kinetic barrier in the cytosolic vestibule is necessary for high Cl^−^ transport rates, which are general characteristics of native CLC channels ([Figure 8](#fig8){ref-type="fig"} and also see ([@bib23])). The results indicate that a small increase in the pore diameter and a decrease in hydrophobicity of the pore lining can substantially lower the kinetic barrier. The structures, however, suggest that the extent might be somewhat less in the CLC-1 channel than in the CLC-K channel because of CLC-1's Ser~C ~'transporter-like' conformation. This is in fact consistent with the observation that CLC-1 has vestigial H^+^ transport activity ([@bib45]) and a relatively slow Cl^−^ throughput compared to that of CLC-K channels (1.2--1.8 pS versus 20--30 pS of CLC-K) ([@bib29]; [@bib51]; [@bib54]; [@bib58]). What then causes the Ser~C~ to adopt its flipped-down conformation in the CLC-K channel? In CLC-K, position 425 contains a bulky amino acid (Y425), in contrast to other CLC proteins. In the canonical conformation Ser~C~ would sterically clash with Y425 (e.g., the center-to-center distance between the Ser~C~-Oγ and Y425-Cε atoms would become 2.3 Å). We speculate that this steric incompatibility imposed by the unique Y425 might lead to the flipped-down conformation of Ser~C~ in the CLC-K channel.

The observed low Cl^−^ occupancy at S~cen~ in the CLC-1 structure has a striking resemblance to previous crystallographic observations on EcCLC, wherein S~cen~ remained unoccupied when experiments were performed with Tyr~C~ mutants lacking H^+^ transport activity or with pseudohalides, which permeate without coupled H^+^ transport ([@bib3]; [@bib40]). It has been shown that in EcCLC, low Cl^−^ occupancy correlates with low anion binding affinity ([@bib46]). This comparison suggests a reduced Cl^−^ binding affinity at S~cen~ in CLC-1, although further biophysical measurements will be necessary to confirm this. We speculate that this feature contributes to reduced H^+^ transport and increased Cl^−^ conduction. Possible causes underlying the altered Cl^−^ affinity include the shifted position of Tyr~C~ and subtle changes in positions and orientations of neighboring backbone nitrogen atoms coordinating the Cl^−^ ion. For example, we note that CLC-0/1/2 channels have smaller, more flexible residues (Gly or Ala) at the G483 position, in contrast to Leu, Ile, or Val in CLC transporters.

CLC-1 is now the second structure of a channel-forming CLC, the first being CLC-K ([@bib42]). One of the major features giving rise to channel behavior is a more conductive pore. The structural differences giving rise to the higher Cl^−^ conductivity are fairly subtle: the pore is slightly wider and the chemical properties a little different, accounting for what we propose to be a reduced kinetic barrier. We think there is a very important lesson here. Throughput rates in the range of 10^6^ ions per second do not require a wide pore. We conclude that even if the pore in places is on average narrower than the ion, as long as the lining atoms are favorable to a conducting ion with respect to their electrostatic and chemical properties, and as long as they are sufficiently dynamic (*i.e.* they can move out of the way), then the ion can diffuse through. We offer as an example of this idea, the selectivity filter of K^+^ channels ([@bib62]). The atomic structures show us that in fact the pore's radius between the K^+^ binding sites is smaller than the radius of a K^+^ ion. And yet some K^+^ channels approach throughput rates of 10^8^ per second. It is not surprising to now understand that the radius of the pore in CLC channels and transporters is not very different.

The structures of CLC-1 and CLC-K channels support the idea that CLC channels are 'broken transporters' ([@bib23]; [@bib35]; [@bib39]), where their channel function is built upon a transporter structure with modifications of the gates. The structures demonstrate that relatively small changes in the active site and ion transport pathway of a transporter gives rise to channel function.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\      Designation         Source or reference              Identifiers                                                    Additional information
  or resource                                                                                                                                      
  ---------------------------- ------------------- -------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------------------
  Gene (*Homo sapiens*)        CLCN1               Synthetic                        UniProt: P35523                                                

  Cell line (*Homo sapiens*)   HEK293S GnTI^-^     ATCC                             ATCC: CRL-3022\                                                
                                                                                    RRID:[CVCL_A785](https://scicrunch.org/resolver/CVCL_A785)     

  Cell line (*Spodoptera*\     Sf9                 ATCC                             ATCC: CRL-1711\                                                
  *frugiperda*)                                                                     RRID:[CVCL_0549](https://scicrunch.org/resolver/CVCL_0549)     

  Recombinant DNA reagent      pEG BacMam          doi: 10.1038/nprot.2014.173                                                                     

  Software, algorithm          RELION-2            doi: 10.1016/j.jsb.2012.09.006                                                                  <https://www2.mrc-lmb.cam.ac.uk/relion/index.php?title=Main_Page>

  Software, algorithm          MotionCor2          doi:10.1038/nmeth.4193                                                                          <http://msg.ucsf.edu/em/software/motioncor2.html>

  Software, algorithm          CTFFIND4            10.1016/j.jsb.2015.08.008                                                                       <http://grigoriefflab.janelia.org/ctffind4>

  Software, algorithm          Alightpart_lmbfgs   doi: 10.1016/j.jsb.2015.08.007                                                                  <https://sites.google.com/site/rubinsteingroup/direct-detector-align_lmbfgs>

  Software, algorithm          Rosetta             RosettaCommons                   RRID:[SCR_015701](https://scicrunch.org/resolver/SCR_015701)   <https://www.rosettacommons.org/software>

  Software, algorithm          Pymol               PyMOL Molecular Graphics\        RRID:[SCR_000305](https://scicrunch.org/resolver/SCR_000305)   <http://www.pymol.org/>
                                                   System, Schrödinger, LLC                                                                        

  Software, algorithm          UCSF Chimera        UCSF Resource for\               RRID:[SCR_004097](https://scicrunch.org/resolver/SCR_004097)   <http://plato.cgl.ucsf.edu/chimera/>
                                                   Biocomputing, Visualization,\                                                                   
                                                   and Bioinformatics                                                                              
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Protein expression and purification {#s4-1}
-----------------------------------

Human CLC-1 was expressed in HEK293 GnTI^−^ cells (ATCC CRL-3022) by transduction using a modified baculovirus as described previously ([@bib19]; [@bib42]). A human CLC-1 coding sequence (CDS) was synthesized and inserted into a modified pFastBac vector, which contains a CMV promoter upstream of CDS. The expressed CLC-1 construct has a truncation of N-terminal 80 amino acids (residues 2--80), which were predicted to be unstructured, and its C-terminus is fused to enhanced green fluorescent protein (eGFP) (it also contains a HRV 3C protease cleavage sequence between CLC-1 and eGFP). The vector was used for transformation of DH10Bac *E. coli* cells (Invitrogen) to generate a baculovirus bacmid. Baculoviruses were produced by transfecting *Spodoptera frugiperda* (Sf9; ATCC CRL-1711) cells with the bacmid using Cellfectin-II (Invitrogen). Viruses were then amplified twice for large-scale transduction. HEK293 GnTI^−^ cells were grown at 37°C in suspension in Freestyle 293 medium (Invitrogen) supplemented 2% FBS in the presence of 8% CO~2~. At a cell density of \~2.5 × 10^6^ mL^−1^, baculovirus was added to the culture (6--8% v/v). After incubating at 37°C for \~0.5 day, the culture was supplemented with 10 mM sodium butyrate, then further incubated at 30°C for 2 days before harvest.

All protein purification steps were carried out at 4°C. Harvested HEK293 cells (typically from 1 to 2 L) were suspended in a buffer containing 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 1 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA), and 10% v/v glycerol, and supplemented with protease inhibitors (50 μM leupeptin, 1 ug/mL aprotinin, 1 uM pepstatin and 1 mM phenylmethylsulfonyl fluoride). 1% dodecyl-β-maltoside (DDM) and 0.2% cholesteryl semisuccinate (CHS) were added to the cell suspension. After extraction for 1.5 h, the lysate was clarified by centrifugation (Beckman Type 70Ti rotor, 40,000 RPM, 1.5 h). The clarified lysate was then mixed with 5 mL of CNBr-sepharose beads (GE Healthcare) coupled with anti-GFP nanobody for 2.5 h. Beads were washed on 60 mL of the buffer containing 0.04% DDM and 0.004% CHS. Bound protein was released from beads by overnight incubation with 5 mL buffer containing 0.04% DDM, 0.004% CHS, and 0.2 mg HRV 3C protease. The retrieved protein was concentrated to 0.5--1.0 mL using Amicon Ultra (100 kDa cutoff; EMD Millipore) and applied to a Superose 6 300/10 GL column (GE Healthcare) equilibrated with 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 0.04% DDM, and 0.004% CHS. The peak fractions were pooled and concentrated to \~4 mg/mL, and immediately used for cryo-EM grid preparation.

The wild-type and mutant *E. coli* CLC transporter proteins (EcCLC) were expressed and purified essentially as described previously ([@bib9]). *E. coli* BL21 (DE3) (Novagen) was transformed by pET28b vector containing EcCLC CDS, the C-terminal of which was fused to a hexa-histidine tag (His-tag). *E. coli* cells were grown at 37°C in Luria broth (LB) medium containing 60 μg/mL kanamycin until they reached OD600 of 1.2. The expression was induced by addition of 0.2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The cells were further grown at 21°C for \~16 h before harvest by centrifugation. The cell pellets were frozen with liquid N~2~ and stored at −80°C until purification. The frozen *E. coli* cells (typically from 3 L) were thawed and suspended in 20 mM Tris-HCl pH 7.5 and 150 mM NaCl. The cells were lysed by sonication (1 mM PMSF and 50 uM leupeptin were supplemented before the lysis), and 2% decylmaltoside (DM) and 10 mM imidazole were added. After 2-h gentle stirring at 4°C, the lysate was spun for 1 h at 15,000 rpm (Beckman JA-17 rotor). The supernatant was mixed with 5 mL of Talon cobalt agarose beads (Takara Bio) for 2 h. The beads were packed in a column and washed with 25 mL of lysis buffer containing 20 mM imidazole, 12.5 mL of buffer containing 30 mM imidazole, and then 12.5 mL of buffer containing 40 mM imidazole. The protein was eluted by buffer containing 200 mM imidazole. The eluate was concentrated to \~0.5 mL using Amicon Ultra (50 kDa cutoff). The His-tag was removed by adding 0.5 U of Lys-C endopeptidase (Roche) and incubating the mixture at 23°C for 3 h. The eluate was applied to a Superdex 200 300/10 GL column (GE Healthcare) equilibrated with 25 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 10% glycerol, and 0.3% DM. The peak fraction was collected and used for reconstitution without freezing.

Cryo-EM analysis {#s4-2}
----------------

3 μL of purified CLC-1 protein was applied to a glow-discharged gold (or copper for the third dataset) Quantifoil R 1.2/1.3 holey carbon grids (Quantifoil) and incubated for 15 s. Grids were then blotted for 1.5--2.0 s at 4°C and 90% humidity and plunge-frozen in liquid-nitrogen-cooled liquid using Vitrobot Mark III (FEI).

The data sets were collected on a Titan Krios electron microscope (FEI) operated at an acceleration voltage of 300 kV. Dose-fractionated images were recorded on a K2 Summit direct electron detector (Gatan) operated in super-resolution counting mode (a super-resolution pixel size of 0.515 Å) using SerialEM software ([@bib36]). For the first two datasets (2293 movies), the dose rate was 8 e^−^ per pixel per s, and total exposure time was 10 s with 0.2 s for each frame (total cumulative dose of \~75 e^−^ per Å^2^ over 50 frames). For the third dataset (1998 movies), the dose rate was 5.33 e^−^ per pixel per s, and total exposure time was 15 s with 0.15 s for each frame (total cumulative dose of \~75 e^−^ per Å^2^ over 100 frames). Defocus values were set from −0.8 μm to −2.4 μm.

Dose-fractionated movies were corrected for gain and motion by MotionCor2 ([@bib61]). Also the pixels were binned to 1.03 Å/pixel during this process. Defocus values were estimated using CTFFIND4 ([@bib48]) on the summed micrographs produced by MotionCor2 (using the full dose). Particles were picked automatically by RELION2 ([@bib27]; [@bib53]), and obvious artifacts, such as ice contamination and carbon foil, were removed by manual inspection. Total 725,959 particles were extracted with a box size of 320 pixels and subjected to reference-free 2D classification (performed separately per dataset). Based on visual inspection of quality of 2D average classes, 411,260 particles were pooled. This particle set was then applied to the alignpart_lmbfgs program ([@bib49]) to perform per-particle motion correction (particle polishing). The particle polishing step was done using motion-corrected (whole-frame-only) movie stacks, which were first produced by MotionCor2 and then 2x or 4x frame-binned by relion_image_handler (resulting in a total of 25 frames per movie and 3 e^−^ per Å^2^ per frame). Particles were extracted from 1 to 13 frames (total dose of 39 e^−^ per Å^2^) and using alignparts_lmbfgs's exposure filter. The 'polished' particles were subjected to another round of clean-up by RELION 2D classification (resulting in 350,750 particles). The initial model was generated by RELION auto-refine using particle images from the first dataset and a 50 Å lowpass-filtered model from the CLC-K channel density map (excluding antibody fragments; ([@bib42])). All 350,750 polished particle images were subjected to auto-refine (RELION 2.1), using the updated initial model and a soft mask surrounding the protein and detergent micelle density. This refinement step produced a 3.8 Å map ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). This was then followed by a RELION 3D classification procedure skipping image alignment (sorting into five classes). Particles from two classes were combined (175,613 particles) by visual inspection in UCSF Chimera ([@bib43]) and subjected to RELION auto-refine again. During the later iterations (upon entering the local search mode), the soft mask was updated to contain only the transmembrane or cytosolic domain (focused refinement). The resolution of the final TMD domain map (3.36 Å) was estimated by RELION based on gold-standard Fourier shell correlation (FSC) of independently refined half maps (using the 0.143 cut-off criterion). The focused refinement of the cytosolic domain was performed by 2 iterations of local refinement using reference maps in which information at lower than 4.6 Å resolution were combined from the previous iteration's two half maps. The nominal resolution of the final CTD map is 4.1 Å, but this is likely somewhat overestimated (the resolution before the focused refinement is 4.5 Å). Local resolution was estimated using RELION2's postprocess program ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Unless stated otherwise, the TMD map shown in figures is a combined map, which was sharpened (B-factor of −97.9 Å^2^) and lowpass-filtered at 3.36 Å by RELION's automatic postprocess procedure using user-provided soft masks. The TMD map in [Figure 2C](#fig2){ref-type="fig"} and [Videos 1](#video1){ref-type="video"} and [2](#video2){ref-type="video"} was sharpened with a B-factor of −97.9 Å^2^ and low-pass filtered at 3.1 Å. The CTD density map was low-pass filtered at 4.2 Å without B-factor sharpening.

Atomic model building {#s4-3}
---------------------

An initial model of the CLC-1's TMD was generated by the SWISS-MODEL homology modelling webserver using the CLC-K model (PDB ID: 5TQQ) as a template. The output model was fit into the TMD density map using Chimera and rebuilt using Coot ([@bib11]). Model refinement was done in real space using Rosetta 3.7 using a script developed for cryo-EM model refinements ([@bib57]) ([Table 1](#table1){ref-type="table"}). The first round was performed with an asymmetric unit model, and the five best output models were selected based on Rosetta's energy scores. A consensus model was generated by combining fragments from these models based on the fit to the density map. The subsequent two rounds of Rosetta refinement were done with two-fold symmetry imposed. To prevent overfitting, the weight between Rosetta energy scores and the fit to the experimental density map was adjusted, and test refinement was performed on one of two half maps. The output models were then compared to both half maps by calculating FSC ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). To this end, we used a weight of 25, which gave us a good fitting to the map and negligible overfitting. While the first two rounds of refinement were done using one of the two half maps, the last round was performed on the combined map to maximize the use of experimental data in refining the model (see [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} for FSC between the final model and the combined map). The final model was selected among \~2000 Rosetta-generated models based on Rosetta's total score (top 20%) and the fit of side chains to the map (visual inspection). No further modifications were made except for Cl^−^ ions at S~ext~ and S~int~, which were modelled in Coot (Coot's real-space refinement was used) since Rosetta could not refine Cl^−^ ions. Modelling of CTD was done similarly using Rosetta, but using a crystal structure of CLC-0 CBS domain as an initial model. A weight of 7 was used, and the refinement was limited to 4.5 Å resolution. As side chains were not visible in the CTD density map, we removed all side chain atoms from the final CTD model generated by Rosetta. The following segments were not modelled as they were invisible in the density maps: N--115, 251--262 (a cytosolic segment between αF and αG), 671--796 (a loop in CTD), and 877--988(C). MolProbity was used for structural validation of models ([Table 1](#table1){ref-type="table"}) ([@bib7]).

10.7554/eLife.36629.019

###### Model refinement and validation statistics.

                                    TMD            CTD
  --------------------------------- -------------- ----------------
  Rosetta Model Refinement                         
  Map pixel size (Å)                1.03           1.03
  Map sharpening B-factor (Å^2^)    −97.9          0
  Map lowpass filter (Å)            3.36           4.2
  Refinement resolution limit (Å)   3.36           4.5
  Number of atoms                   14,536         5124^†^
   Protein                          14,536         5124^†^
    Non-hydrogen atoms              7152           2550^†^
    Hydrogen atoms                  7384           2574^†^
   Non-protein                      0              0
  **Refined Model Statistics**                     
  Average B-factor (Å^2^)           24.59          161.34
  r.m.s deviations                                 
   Bond length (Å)                  0.02           0.02^†^
   Bond angle (°)                   1.42           1.55^†^
  Ramachandran Plot                                
   Favored (%)                      96.75          96.15^†^
   Outliers (%)                     0.43           0.64^†^
  MolProbity                                       
   Clash score\*/percentile         1.38 (99 %)    0.39^\#^ (99%)
   Rotamers                                        
    Favored (%)                     99.48%         100.00^\#^ %
    Outliers (%)                    0.00%          0.0^†^ %
  Overall score/percentile          1.07 (100 %)   0.90^†^ (100%)

\*number of steric overlaps \>0.4 Å per 1000 atoms.

^†^numbers and scores before truncation of side chain atoms.

Detection of pores and estimation of pore radii ([Figures 3](#fig3){ref-type="fig"} and [6](#fig6){ref-type="fig"}) were performed using Caver ([@bib8]). In the case of EcCLC (PDB ID: 1OTS) and CmCLC (PDB ID: 3ORG), Glu~gate~ (E148 of EcCLC and E210 of CmCLC) was mutated to Ala before estimation since its side chain is blocking the Cl^−^ pathway. In the case of bovine CLC-K (PDB ID: 5TTQ) ([Figure 6B](#fig6){ref-type="fig"}), we changed the rotamer conformation of V166 (equivalent to Glu~gate~) from original *gauche+* (63°) to *trans* (175°). With the original rotamer, the constriction around S~ext~ was found to be too narrow (radius \< 0.9 Å) for pore detection. Because both rotamers can be fitted equally well into the cryo-EM density map, it is uncertain which is right or if both can exist in the protein. We note that *trans* is in general an energetically more favored rotamer than *gauche+*. Water accessibility in CLC-1's vestibules ([Figure 4B](#fig4){ref-type="fig"}) was probed using HOLLOW ([@bib21]) using a probe radius of 1.4 Å. Protein electrostatics were calculated using the Adaptive Poisson-Boltzmann Solver ([@bib5]) with a parameter of 150 mM monovalent salt concentration. UCSF Chimera and PyMOL (Schrödinger) were used to prepare structure figures.

Reconstitution of E. coli CLC transporter mutants and flux assays {#s4-4}
-----------------------------------------------------------------

To reconstitute EcCLC mutant proteins for Cl^−^ efflux assays, *E. coli* polar lipids in chloroform (Avanti Polar Lipids) was dried in a glass tube with an argon stream, followed by overnight incubation in a vacuum chamber. Dried lipids were suspended by sonication in buffer (RB-Cit) containing 25 mM sodium citrate (pH 4.6) and 300 mM KCl and then solubilized with 35 mM (3-((3-cholamidopropyl) dimethylammonio)−1-propanesulfonate) (CHAPS; Anatrace) and additional sonication. Purified EcCLC protein was added to the lipid/CHAPS mixture in a protein-to-lipid ratio of 1:5000 (wt:wt). After 30 min incubation at 23°C, the mixture was dialyzed against RB-Cit buffer to remove CHAPS. The dialysis was carried out at 4--10°C for 48 h with three additional buffer changes. To reconstitute EcCLC proteins for fluorescence-based flux assays, the same procedure was used except that buffer containing 10 mM HEPES-NaOH (pH 7.0) and 450 mM KCl instead of RB-Cit and a protein-to-lipid ratio of 1:500 (wt:wt) were used. After dialysis, proteoliposome vesicles were aliquoted, flash-frozen with liquid N~2~, and stored at −80°C until use.

The Cl^−^ efflux (dump) assays were performed essentially as described previously ([@bib23]; [@bib56]). A frozen aliquot of vesicles was thawed and briefly sonicated in the bath sonicator (Branson). Vesicles were extruded through a 0.4 μm polycarbonate filter 19 times (Avanti Mini-Extruder). The extruded vesicles were desalted with a spin column packed with Sephadex G-50 resin (\~2.5 mL bed volume) equilibrated with buffer (EB) containing 25 mM sodium citrate (pH 4.7), 250 mM K~2~SO~4~, and 1 mM NaCl. 100 μL of the desalted vesicles were then mixed with 900 μL EB in a chamber equipped with a magnetic stirrer and Cl^−^-selective electrode (Fisher Accumet). Changes in extravesicular Cl^−^ concentration was monitored over time by the Cl^−^-selective electrode connected to a computer through a digitizer (DataQ). To calibrate the electrode, 0.1 mM NaCl was added before the vesicles were added. Flux was initiated by addition of 2 μg/mL valinomycin and 1 μg/mL carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) or 3 μg/mL valinomycin (for E148A mutants). At the end of assays, 30 mM octyl β-glucoside (Anatrace) was added to release all Cl^−^ content from vesicles. Calculation of Cl^−^ transport rates were carried out as described previously ([@bib56]). Volume changes by dialysis, extrusion, and desalting steps were included in calculation.

The fluorescence-based flux assays were performed as follows based on ([@bib16]). A frozen aliquot of vesicles was thawed and briefly sonicated in a bath sonicator. 3 μL of vesicles were mixed with 40 μL of assay buffer containing 20 mM HEPES-NaOH (pH 7.0), 450 mM K-gluconate and 4 μM ACMA in a well of a 384-well fluorescence assay. After measuring initial AMCA fluorescence intensity (λ~Ex~=410 nm, λ~Em~=490 nm), Cl^−^/H^+^ flux was initiated by addition of 1 μM valinomycin, followed by monitoring fluorescence over time (10 s intervals) using a plate reader (Tecan Infinite M1000) at 27°C. Note that there is a dead time for measurement between t = 80 s to t = 120 s due to handling of the plate during valinomycin addition. Valinomycin was added to the reactions at t = \~100 s. As a control, 0.9 μM carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to the assay mixture at the end of the experiment to dissipate an accumulated H^+^ gradient. To measure relative H^+^ transport activity of each mutant, time required to fluorescence reaches 75% (or 85% in the case of S106G/F348A double mutant) of the initial fluorescence upon addition of valinomycin was calculated. This time value was then inversed and normalized with respect to a value obtained with wild-type EcCLC.
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Cryo-EM density maps of human CLC-1 have been deposited in the electron microscopy data bank under accession code EMD-7544 and 7545. Atomic coordinates have been deposited in the protein data bank under accession code 6COY and 6COZ.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Structure of the CLC-1 chloride channel from Homo sapiens\" for consideration by *eLife*. Your article has been favorably evaluated by Richard Aldrich (Senior Editor) and three reviewers, one of whom, László Csanády (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individuals involved in review of your submission have agreed to reveal their identity: Alessio Accardi (Reviewer \#2); Christopher Miller (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript by Park and Mackinnon presents the first high-resolution (\~3.4Å) structure of a human CLC channel, hCLC-1, solved by electron-cryomicroscopy. The overall architecture of the homodimeric protein is very similar to those of other solved CLC-family structures, and includes in each subunit a pore which is bifurcated on the cytosolic side and harbors three anion binding sites (S~ext~, S~cen~, S~int~). On the other hand, subtle differences in pore diameter and the side-chain chemistry of pore-lining residues helps to understand the very different functional properties of members of the channel and transporter subclass of the CLC family. The authors propose that channel-like behavior is due to (i) a reduced kinetic barrier for Cl^-^ flux between S~cen~ and S~int~, (ii) low-affinity anion binding in S~cen~, and (iii) a permissive (off-pore) position of the side-chain of the \"gating glutamate\" (Glu~gate~). These predictions are elegantly supported by functional analysis of a bacterial CLC transporter (EcCLC) mutated at various key positions. Overall, this is an excellent manuscript with no major concerns noted by the reviewers. Below are suggestions for three points that would benefit from a few more sentences of discussion, to help harmonize their mechanistic model with pre-existing data and literature.

Essential revisions:

1\) Despite the off-pore position of Glu~gate~, the diameter of the external pore entrance is still too narrow to accommodate an ion. While this is not shocking, as all the CLC structures share this feature, it is still puzzling how such a pore can conduct ions at a rate of \~10^6^ ions s^-1^. Along these lines, it would be helpful if the authors could discuss a bit more on Cl^-^ throughput rates, and say something about the issue of electro-diffusive vs. uniporter-like Cl^-^ flux.

2\) CLC-1 is activated by extracellular pH. The current consensus open pore was Glu~gate~ in the \'up\' (E148Q-like structure of CLC-ec1) conformation. This explained well how CLC-1 could be activated by e.c. low pH, as Glu~gate~ would be accessible to water and H^+^ from the extracellular solution and stabilized in this state. If the sideways conformation of the Glu~gate~ side chain seen in the new structure indeed reflects the open pore, then it is hard to envision how that side chain is protonated from the extracellular side, and how protonation would stabilize this state. Thus, it would be helpful if the authors could comment on the mechanism of CLC-1 activation by extracellular low pH.

3\) The cartoon in Figure 7C suggests that the Glu~gate~ side chain is itself the fast protopore gate. However, E-to-A mutations of Glu~gate~ in Clc-0 (Dutzler et al., 2003), and evolutionary removal of Glu~gate~ in Clc-K (L\'Hoste et al., 2013, PMID: 23791703), result in channels in which the protopores are still seen to gate (open and close), albeit with high open probabilities. Wouldn\'t this suggest that the fast gate is not simply formed by the Glu~gate~ side chain? Could the brief fluctuations of those channels reflect small movements of the pore lining residues that temporarily block permeation through the narrow channel pore?
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Author response

> Essential revisions:
>
> 1\) Despite the off-pore position of Glu~gate~, the diameter of the external pore entrance is still too narrow to accommodate an ion. While this is not shocking, as all the CLC structures share this feature, it is still puzzling how such a pore can conduct ions at a rate of \~10^6^ ions s^-1^. Along these lines, it would be helpful if the authors could discuss a bit more on Cl^-^ throughput rates, and say something about the issue of electro-diffusive vs. uniporter-like Cl^-^ flux.

We added an additional paragraph in the Discussion (sixth paragraph) to address this issue. In brief, we think scientists should change their expectations regarding pore diameter and throughput. Now with data to compare two CLC channel structures and multiple CLC transporter structures we can place data ahead of preconceived notion. We come to the same conclusion independently through the study of other ion channels. Take for example K^+^ channels, in which the selectivity filter between ion binding sites is narrower than the diameter of a K^+^ ion. In the added paragraph we explain that the chemical and electrostatic properties of atoms lining the pore and their dynamic properties (ability to move out of the way) will affect conductivity. This is in fact an old problem in biochemistry considered in other contexts such as diffusion of oxygen to the heme co-factor inside a protein.

> 2\) CLC-1 is activated by extracellular pH. The current consensus open pore was Glu~gate~ in the \'up\' (E148Q-like structure of CLC-ec1) conformation. This explained well how CLC-1 could be activated by e.c. low pH, as Glu~gate~ would be accessible to water and H^+^ from the extracellular solution and stabilized in this state. If the sideways conformation of the Glu~gate~ side chain seen in the new structure indeed reflects the open pore, then it is hard to envision how that side chain is protonated from the extracellular side, and how protonation would stabilize this state. Thus, it would be helpful if the authors could comment on the mechanism of CLC-1 activation by extracellular low pH.

We added a paragraph (Discussion, third paragraph) discussing this issue. As described there are several possible explanations but the bottom line is we do not understand this yet.

> 3\) The cartoon in Figure 7C suggests that the Glu~gate~ side chain is itself the fast protopore gate. However, E-to-A mutations of Glu~gate~ in Clc-0 (Dutzler et al., 2003), and evolutionary removal of Glu~gate~ in Clc-K (L\'Hoste et al., 2013, PMID: 23791703), result in channels in which the protopores are still seen to gate (open and close), albeit with high open probabilities. Wouldn\'t this suggest that the fast gate is not simply formed by the Glu~gate~ side chain? Could the brief fluctuations of those channels reflect small movements of the pore lining residues that temporarily block permeation through the narrow channel pore?

The evidence that Glu~gate~ dominates protopore gating is strongly supported by data. When Glu~gate~ is mutated you do see some residual (much less frequent) gating/blocking events that are likely due to other changes in pore conformation or block (likely, because almost all ion channels exhibit such closing events). Therefore, no, these observations do not suggest to us that the fast gate is not formed by Glu~gate~.
